Accelerate Diagnostics Inc expected to post a loss of 19 cents a share - Earnings Preview

Accelerate Diagnostics

12/11/2022 24:13

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 14. 
    * The Denver Colorado-based  company is expected to report 
a
20.1% increase in revenue to $3.751 million from $3.12 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $4​, above​ its last closing price of $1.42.
​​​

This summary was machine generated November 12 at 00:13 GMT. 
All figures in US dollars  unless otherwise stated